Hydromorphone HCl (OROS formulation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hydromorphone HCl (OROS formulation), covering 2010-04-27 to 2010-04-27. Get the full timeline:
Most recent: Clinical Trial Update: A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer Pain [Phase 3]